BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2643544)

  • 1. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.
    Oguma S; Belle S; Starzl TE; Demetris AJ
    Hepatology; 1989 Feb; 9(2):204-9. PubMed ID: 2643544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron microscopy of rejected human liver allografts.
    Fennell RH; Vierling JM
    Hepatology; 1985; 5(6):1083-7. PubMed ID: 3905559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of pretransplant hepatobiliary disease to bile duct damage occurring in the liver allograft.
    Fennell RH; Shikes RH; Vierling JM
    Hepatology; 1983; 3(1):84-9. PubMed ID: 6295909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and pathogenesis of intrahepatic bile duct loss.
    Nakanuma Y; Tsuneyama K; Harada K
    J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis.
    Nakanuma Y; Ohta G
    Gastroenterology; 1979 Jun; 76(6):1326-32. PubMed ID: 437429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rejection of liver transplants revisited.
    Deligeorgi-Politi H; Wight DG; Calne RY; White DG
    Transpl Int; 1994; 7(6):442-7. PubMed ID: 7865110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and treatment of bile duct loss after liver transplantation.
    Inomata Y; Tanaka K
    J Hepatobiliary Pancreat Surg; 2001; 8(4):316-22. PubMed ID: 11521176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
    Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
    Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts.
    Vierling JM; Fennell RH
    Hepatology; 1985; 5(6):1076-82. PubMed ID: 3905558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection.
    Wiesner RH; Batts KP; Krom RA
    Liver Transpl Surg; 1999 Sep; 5(5):388-400. PubMed ID: 10477840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin immunostaining for detection of biliary epithelium: its use in counting bile ducts in cases of liver allograft rejection.
    Harrison RF; Patsiaoura K; Hubscher SG
    J Clin Pathol; 1994 Apr; 47(4):303-8. PubMed ID: 7517955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total fibrous obliteration of main portal vein and portal foam cell venopathy in chronic hepatic allograft rejection.
    Jain D; Robert ME; Navarro V; Friedman AL; Crawford JM
    Arch Pathol Lab Med; 2004 Jan; 128(1):64-7. PubMed ID: 14692809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cholangitis: liver allograft rejection and graft-versus-host disease.
    Demetris AJ
    Mayo Clin Proc; 1998 Apr; 73(4):367-79. PubMed ID: 9559043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis.
    Ludwig J; MacCarty RL; LaRusso NF; Krom RA; Wiesner RH
    Hepatology; 1986; 6(4):560-8. PubMed ID: 3525365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft versus host disease.
    Bernuau D; Feldmann G; Degott C; Gisselbrecht C
    Hum Pathol; 1981 Sep; 12(9):782-93. PubMed ID: 7030921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in the human liver during allograft rejection and end-stage liver disease.
    Afford SC; Hubscher S; Strain AJ; Adams DH; Neuberger JM
    J Pathol; 1995 Aug; 176(4):373-80. PubMed ID: 7562252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis.
    Harrison RF; Hubscher SG
    Histopathology; 1991 Oct; 19(4):321-7. PubMed ID: 1937411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased bile duct complications in liver transplantation across the ABO barrier.
    Sanchez-Urdazpal L; Batts KP; Gores GJ; Moore SB; Sterioff S; Wiesner RH; Krom RA
    Ann Surg; 1993 Aug; 218(2):152-8. PubMed ID: 8342994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree.
    van den Heuvel MC; de Jong KP; van der Horst ML; Poppema S; Slooff MJ; Gouw AS
    Liver Transpl; 2004 Jan; 10(1):28-35. PubMed ID: 14755774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.